— Pfizer Inc. (@pfizer) October 7, 2021
Pfizer announced Thursday that they had submitted an emergency request to the FDA for authorization of the two-dose Covid vaccine in children ages 5 to 11.
“With new cases in children in the U.S. continuing to be at a high level, this submission is an important step in our ongoing effort against #COVID19,” Pfizer tweeted. “We’re committed to working with the FDA with the ultimate goal of helping protect children against this serious public health threat.”
An FDA advisory committee plans to meet to discuss authorization on Oct. 26.
White House COVID Response Coordinator Jeff Zients says COVID vaccine for children could be ready before Thanksgiving following Pfizer’s request for Emergency Use Authorization this morning. pic.twitter.com/YSmumKmJrR
— The Recount (@therecount) October 7, 2021